| Line item | 2025-04-30 FY | 2024-04-30 FY | 2023-04-30 FY | 2022-04-30 FY | 2021-04-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $43.73K | $2.04M | $54.45K | $29.84K | $27.65K |
| R&D | – | – | – | – | – |
| SG&A | $41.77K | $40.08K | $45.95K | $29.84K | $27.65K |
| Operating Income | -$43.73K | -$2.04M | -$54.45K | -$29.84K | -$27.65K |
| Interest Expense | $6.80K | $6.79K | $7.74K | $2.04K | $665.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$50.53K | -$2.05M | -$40.74K | -$270.49K | $5.80K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | -0.0100 | -0.4100 | – | – | – |
| Shares (diluted) | $5.67M | $5.03M | – | – | – |